Singapore markets close in 6 hours 36 minutes

Straits Times Index
3,312.91
-9.17(-0.28%)
Nikkei
39,163.56
+125.40(+0.32%)
Hang Seng
18,035.93
-331.02(-1.80%)
FTSE 100
8,228.48
-16.89(-0.20%)
Bitcoin USD
68,123.76
-1,608.60(-2.31%)
CMC Crypto 200
1,423.33
-23.34(-1.61%)

SNY Sep 2024 42.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

7.40

0.00

(0.00%)

As of 03:56PM EDT. Market open.

Loading interactive chart…

Zacks
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
Zacks
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR Newswire
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer. Dr. Dennis, who will join I-Mab effective June 17, 2024, will lead the Company's global clinical development efforts and serve as a member of I-Mab's Executive Leadership Team.